S&P 500 7,561.67 −0.40%
Nasdaq 25,136.27 −0.91%
S&P/TSX 36,105.90 −0.09%
Apple 356.27 +0.39%
Nvidia 162.85 −2.01%
Microsoft 523.88 +0.17%
Shopify 209.74 +0.16%
Royal Bank 288.37 −0.35%
CAD/USD 0.7008 −0.06%
CLOSED · 13:45 ET
Market ClerkRecap
Sat Nov 14 · markets closed3 signals today368 insider buys this week · $138.2MCIRO short report next: Nov 15The week ahead
CC
INSIDER · ETON · Eton Pharmaceuticals, Inc. · DIRECTOR

CASAMENTO CHARLES J

Every open-market transaction filed under this name, Nov 10 to Nov 10.

Filings
5
0 buys · 5 sells
Bought
—
open market, at cost
Sold
$5.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Nov 10ETONEton Pharmaceuticals, Inc.DirectorSell2,903$67.87$197K−9.5%
Nov 10ETONEton Pharmaceuticals, Inc.DirectorSell33,956$67.11$2.3M−8.4%
Nov 10ETONEton Pharmaceuticals, Inc.DirectorSell22,601$66.26$1.5M−7.3%
Nov 10ETONEton Pharmaceuticals, Inc.DirectorSell14,715$65.32$961K−5.9%
Nov 10ETONEton Pharmaceuticals, Inc.DirectorSell6,380$64.33$410K−4.5%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.